Prognosis and response to therapy can be efficiently predicted by a combination of cytogenetic aberrations, detected by interphase-FISH in newly diagnosed multiple myeloma patients
median age was 55.5 years (range, 27 to 84 years) with male preponderance. IgH translocation group (P<0.042) and TP53 deletion (P<0.052) were identified as high-risk group ... gain (1q21) were independent high-risk…

